Search results
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 4 days agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via Yahoo News· 6 hours agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 4 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 7 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 4 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 2 days agoDuring the last session, Moderna Inc (NASDAQ:MRNA)’s traded shares were 4.04 million, with the beta value of the company hitting 1.70. At the end of the trading day, the stock ...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 4 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 5 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
Acadia (ACAD) Up 0.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 5 hours agoPerformance of an Industry Player Acadia is part of the Zacks Medical - Biomedical and Genetics...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 4 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...